Moelis & Co Reports Strong 2025 Results, Declares Dividend, and Authorizes $300M Share Buyback
MC sits 55% above its 52-week low of $47.
Summary
Moelis & Company announced strong Q4 and full-year 2025 financial results, including significant revenue and earnings growth, alongside a new $300 million share repurchase authorization and a regular quarterly dividend.
Key Events · Earnings and Guidance · MC
-
Strong 2025 Financial Performance
Full year Adjusted revenues increased 28% to $1.54 billion, with Adjusted diluted EPS rising 64% to $2.99, demonstrating robust growth and improved profitability.
-
Significant Share Repurchase Authorization
The Board approved a new share repurchase authorization of up to $300.0 million, signaling strong management confidence and a commitment to returning capital to shareholders.
-
Consistent Capital Return
A regular quarterly dividend of $0.65 per share was declared, reinforcing the company's stable capital return policy.
-
Robust Balance Sheet
The company maintains a strong financial position with $848.8 million in cash and liquid investments and no debt or goodwill.
Analysis · MC · Finance
The filing details robust financial performance for Moelis & Company in 2025, marked by substantial revenue and earnings growth. The company's commitment to shareholder returns is underscored by a new, significant share repurchase authorization and a consistent quarterly dividend. This strong financial health and strategic capital allocation are positive indicators for investors.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 40.9% of the 320 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MC was trading at $72.74 on NYSE in the Finance sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $47.00 to $82.89. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.